Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.85
Bid: 47.20
Ask: 47.85
Change: -0.50 (-1.03%)
Spread: 0.65 (1.377%)
Open: 46.80
High: 48.85
Low: 45.65
Prev. Close: 48.35
OMU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Old Mutual plc - Results from bondholder meetings

12 Nov 2018 12:15

RNS Number : 0704H
Old Mutual Limited
12 November 2018
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

NSX Share Code: OMM

("Old Mutual")

 

Ref 74/2018

12 November 2018

NOT FOR DISTRIBUTION INTO ANY JURISDICTION OR TO ANY PERSON WHERE OR TO WHOM IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

 

RESULTS OF BONDHOLDER MEETINGS

 

OLD MUTUAL SUBSIDIARY OLD MUTUAL PLC ANNOUNCES (I) THE RESULTS OF SEPARATE ADJOURNED NOTEHOLDER MEETINGS OF ITS OUTSTANDING £500,000,000 8 PER CENT. SUBORDINATED NOTES DUE 3 JUNE 2021 AND ITS OUTSTANDING £450,000,000 7.875 PER CENT. SUBORDINATED NOTES DUE 3 NOVEMBER 2025 TO APPROVE BY WAY OF EXTRAORDINARY RESOLUTION CERTAIN MODIFICATIONS TO THE TERMS AND CONDITIONS OF THE RELEVANT SERIES AND THE RELEVANT TRUST DEED CONSTITUTING THE RELEVANT SERIES AND (II) THE EXECUTION OF SUPPLEMENTAL TRUST DEEDS

 

The body of the Old Mutual plc announcement (as published on the London Stock Exchange website) is set out below.

----------------------------------------------------------------------------------------------------------------------------------

Old Mutual plc (the "Company") announces (I) THE RESULTS OF SEPARATE ADJOURNED NOTEHOLDER MEETINGS of its outstanding £500,000,000 8 PER CENT. SUBORDINATED NOTES DUE 3 JUNE 2021 (the "2021 Securities") AND ITS OUTSTANDING £450,000,000 7.875 PER CENT. SUBORDINATED NOTES DUE 3 NOVEMBER 2025 (the "2025 Securities" and, together with the 2021 Securities, the "Securities", and each a "Series") (the "adjourned meetings") to approve by way of extraordinary resolution certain modifications to the terms and conditions of the relevant series and the relevant trust deed constituting the relevant series AND (II) THE EXECUTION OF SUPPLEMENTAL TRUST DEEDS

On 26 September 2018, the Company announced its separate invitations to holders of its 2021 Securities (the "2021 Securityholders") and to holders of its 2025 Securities (the "2025 Securityholders" and, together with the 2021 Securityholders, the "Securityholders") in each case to approve, by way of Extraordinary Resolution, the relevant Proposal, comprising certain modifications to the terms and conditions of the relevant Series (in respect of such Series, the "Conditions") and the trust deed constituting the relevant Series as further detailed in the Consent Solicitation Memorandum dated 26 September 2018 (the "Consent Solicitation Memorandum"), subject, in each case, to the terms and conditions set out in the Consent Solicitation Memorandum, as amended by the announcement of the Company dated 25 October 2018 announcing the convening of the Adjourned Meetings (the "Adjourned Meetings Announcement"). Capitalised terms used in this announcement but not defined have the meanings given to them in the Consent Solicitation Memorandum (as amended by the Adjourned Meetings Announcement).

The Consent Deadline expired at 4.00 p.m. (London time) on 7 November 2018.

Results of the Proposals

The Adjourned Meetings to consider the Proposals were held earlier today, and NOTICE IS HEREBY GIVEN to Securityholders that:

(a) at the Adjourned Meetings, the relevant Extraordinary Resolutions were duly passed and the relevant Proposals approved;

(b) the relevant Supplemental Trust Deeds referred to in the relevant Extraordinary Resolutions have been executed by the Company and the Trustee, and the relevant Conditions have been amended accordingly;

(c) the Reference Gilt Rates are expected to be determined at or around 11.00 a.m. (London Time) on 13 November 2018 and the Company will announce the Early Redemption Amount in respect of each series of Notes as soon as reasonably practicable thereafter; and

(d) the Company will redeem all Notes of each Series pursuant to the Issuer Early Redemption on 15 November 2018 (the "Settlement Date") at the Early Redemption Amount plus Accrued Interest (if any).

All Securities which are redeemed pursuant to the Issuer Early Redemption will forthwith be cancelled. Securityholders who delivered, or arranged to have delivered on their behalf, a valid Solicitation Instruction in favour of the relevant Extraordinary Resolution which was received by the Tabulation Agent by the Consent Deadline will also receive the Consent Fee on the Settlement Date.

Requests for information in relation to the Consent Solicitation and the Proposals should be directed to:

The Solicitation Agent

Merrill Lynch International

2 King Edward Street

London EC1A 1HQ

United Kingdom

 

Telephone: +44 20 7996 5420

Attention: Liability Management Group

Email: DG.LM_EMEA@baml.com

 

The Tabulation Agent

Lucid Issuer Services Limited

Tankerton Works

12 Argyle Walk

London WC1H 8HA

United Kingdom

 

Telephone: + 44 20 7704 0880

Attention: Arlind Bytyqi

Email: oldmutual@lucid-is.com

DISCLAIMER This announcement must be read in conjunction with the Consent Solicitation Memorandum (as amended by the Adjourned Meetings Announcement). No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement, the Adjourned Meetings Announcement and the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Adjourned Meetings Announcement and/or the Consent Solicitation Memorandum comes are required by each of the Company, the Solicitation Agent and the Tabulation Agent to inform themselves about, and to observe, any such restrictions.

 

----------------------------------------------------------------------------------------------------------------------------------

 

JSE Sponsor

Merrill Lynch South Africa (Pty) Limited

Namibian Sponsor

PSG Wealth Management (Namibia) (Proprietary) Limited

Enquiries

Investor Relations

Patrick Bowes

(Interim Head of Investor Relations)

 

T: +44 (0)20 7002 7440

E: Patrick.bowes@omg.co.uk

Communications:

Tabby Tsengiwe

 

T: +27 (11) 217 1953

M: +27 (0)60 547 4947

E: ttsengiwe@oldmutual.com

 

Notes to Editors

 

About Old Mutual Limited

 

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key markets segments in 17 countries. Old Mutual's primary operations are in South Africa and the rest of Africa, and it has niche businesses in Latin America and Asia. With over 170 years of heritage across sub-Saharan Africa, we are a crucial part of the communities we serve and broader society on the continent.

 

For further information on Old Mutual, and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMLLFVLLTLFLIT
Date   Source Headline
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20233:15 pmRNSDealings in securities on behalf of share trusts
17th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
16th Mar 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
15th Mar 202312:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20237:00 amRNSFinal Results
10th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
9th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
8th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
3rd Mar 202310:00 amRNSForm 8.3 - [Mediclinic International plc]
2nd Mar 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
24th Feb 20237:00 amRNSVoluntary Trading Statement
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding Correction
22nd Feb 20233:30 pmRNSDirector/PDMR Shareholding
7th Feb 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
3rd Feb 20231:00 pmRNSForm 8.3 - [Mediclinic International plc]
27th Jan 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
10th Jan 202311:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Jan 202312:00 pmRNSForm 8.3 - Mediclinic International plc
21st Dec 20221:00 pmRNSForm 8.3 - [Mediclinic International plc]
16th Dec 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 20221:50 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 202211:30 amRNSForm 8.3 - Micro Focus International plc
30th Nov 202212:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Nov 20227:00 amRNSVoluntary Operating Update
21st Nov 20223:00 pmRNSImplementation of the Bula Tsela transaction
18th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
17th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
16th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
11th Nov 20221:30 pmRNSForm 8.3 - Mediclinic International plc
4th Nov 20223:10 pmRNSOld Mutual Bula Tsela Transaction
20th Oct 202212:00 pmRNSForm 8.3 - Mediclinic International plc
14th Oct 202211:00 amRNSForm 8.3 - Mediclinic International plc
13th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
12th Oct 20221:00 pmRNSForm 8.3 - Mediclinic International plc
6th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:00 pmRNSDirectorate Change
23rd Sep 20223:00 pmRNSForm 8.3 - Mediclinic International plc
6th Sep 202210:30 amRNSDirector/PDMR Shareholding
6th Sep 20229:30 amRNSInterim Dividend Currency Equivalents
30th Aug 20227:00 amRNSUnaudited Interim Results and Dividend Declaration
19th Aug 20222:00 pmRNSForm 8.3 - Mediclinic International plc
16th Aug 202212:40 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:30 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:00 pmRNSResults of shareholder voting at GM
11th Aug 20227:00 amRNSTrading Statement
4th Aug 202212:00 pmRNSForm 8.3 - Mediclinic International plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.